Mr Wood faced three charges, all relating to allegations of misconduct over a laboratory test for an alpaca while he was working at a practice in South Oxfordshire.
The charges alleged that in September 2023, Mr Wood told the alpaca’s owner that it had tested positive for Johne’s disease when in fact, the animal had not been tested.
He then allegedly sent a letter confirming a positive test result for the test that had not taken place, and then created a false test result report in the name of a veterinary surgeon colleague and sent it to another colleague by email.
He later told the alpaca's owner that he had given her the wrong result by mistake and that the test result was actually negative.
Then in October 2023, he emailed the laboratory saying that a member of his practice’s administrative staff had written the false report.
In November he told the managing partner of his then employer on three occasions that he was investigating the false report in order to find out who sent it.
Finally, he sent a misleading and dishonest email to a veterinary surgeon colleague falsely indicating that a member of the practice’s staff had manufactured the false report, when that was not the case.
At the outset of the hearing Mr Wood admitted the facts of all the allegations against him.
Having found the facts proven, the Committee found that the charges amounted to serious professional misconduct, something which Mr Wood himself also admitted.
The Committee identified a number of aggravating factors in Mr Woods' conduct, including his lack of honesty, probity and integrity, the fact the conduct was premeditated, that it involved a breach of the client’s trust, the abuse of his professional position, the fact the conduct was sustained and repeated over a period of time, and that his conduct contravened advice given by the RCVS.
The mitigating factors included positive testimonials from professional former colleagues and client farmers, the fact that he had engaged in some remediation in order to avoid repeating the dishonest behaviour, and that he showed significant insight into his misconduct.
Dr Neil Slater MRCVS, chairing the Committee and speaking on its behalf, said: “The Committee recognised that the serious repeated dishonesty, which was to conceal wrongdoing, made the respondent’s misconduct particularly serious.
“It therefore gave consideration as to whether his conduct was fundamentally incompatible with being a veterinary surgeon and whether removal was the only appropriate and proportionate sanction in this case.
“The Committee considered that this was a particularly difficult case to reconcile, as, on the one hand the misconduct was so serious whereas on the other hand, the respondent had demonstrated significant insight; the risk of repetition was low; the evidence of his professional achievements was strong and the testimonials from client farmers and professional colleagues were impressive.”
He added: “The Committee considers that suspension is sufficient in the circumstances of this case to satisfy public confidence in the profession and to uphold proper professional standards of conduct and behaviour.
"The Committee therefore imposes a suspension of 18 months on the respondent.
"In determining this length, the Committee considered that this was the least period necessary in order to meet the significant public interest considerations in this case.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Underlying the strategic plan are what the College says are its four updated values of compassion, collaboration, clarity and courage.
The plan lays out four strategic ambitions, each focused on one of its stakeholder groups, each one under the banner of 'Stronger Together'.
Veterinary professionals: "The RCVS will help veterinary professionals meet high standards and champion accessible, team-based veterinary care, delivered in settings that support professional autonomy and leadership."
This includes reviewing the Code of Professional Conduct and supporting guidance, achieving new veterinary legislation and ensuring that educational standards and career pathways meet the diverse needs of society.
Animal owners and keepers: "The RCVS will support animal health and welfare and public health by enabling access to veterinary care informed by the needs of consumers and service users."
This includes supporting and informing the public in how to get the best from veterinary professionals, with increased transparency, agency and choice.
Society at large: "The RCVS will champion the role that veterinary professionals play in One Health and public health, take a leadership role on environmental sustainability and biodiversity, and continue to look at how it can play a role in the global veterinary professions."
This includes leading the conversation on issues such as the cost of veterinary care, building enthusiasm for veterinary work in the minds of the next generation of potential professionals and ensuring veterinary professionals responsible for public health are well supported with robust standards and safeguards.
Staff team and governance: "The RCVS will attract and retain the diversity of talent and skills to deliver what’s needed now and anticipate what might be next and build a culture that allows people to thrive."
This includes developing an infrastructure for success, including the new RCVS headquarters, and underpinning structures for finance, communications and digital, creating a working culture with sound values and supportive management.
Lizzie Lockett, RCVS Chief Executive Officer, said: “The overall theme of the plan recognises that there are many other individuals and organisations that have a stake in our mission to inspire confidence in veterinary care and protect the public interest by ensuring animal health and welfare, and public health, are advanced through thriving world-class veterinary professions.
“This is where the ‘stronger together’ comes in, recognising that, in our role as a royal college that regulates, we are very well placed to bring people and organisations together to meet our common purpose of improved animal health and welfare and public health in a collaborative, proactive way.”
www.rcvs.org.uk/strategy25
From early 2025, all vets, nurses and technicians will be required to wear a hard hat in the vicinity of a horse, pony or donkey – whether in practice, on a yard, or at a client’s premises.
It follows a three-year research project collaborating with the University of Liverpool which revealed that 90% of veterinary clinicians have experienced an injury during their career.
It is hoped that the move will reduce injuries to the head – one of the most common traumas to be suffered by equine vets identified by the research, usually sustained when examining distal limbs. CVS says that in the US, equine vets sustain on average eight serious injuries during their career, making it the second highest profession for non-fatal injuries.
The University of Liverpool research found that over 25% of equine vet injuries have led to hospital attendance. Dr. John Tulloch, Lecturer and European Specialist in Veterinary Public Health at the University of Liverpool, who led the research, said: “Vet visits are not an ‘everyday activity’ for a horse.
"As a result, many horses will be on heightened alert, and some may be more prone to unpredictable behaviour. “Vets are often in a vulnerable situation when examining a horse.
"And it’s difficult to pick up on a horses’ signals, especially when examining areas such as distal limbs. “Our research found that many injuries happen when a horse kicks or pushes a person over and the person’s head makes impact with the ground.
"So, wearing a hard hat will be a big step towards preventing traumatic head injuries if this were to happen.” Sophie Ignarski, Equine Director at CVS said: “All of our clinicians are at risk in their day-to-day work – whether they are newly qualified or very experienced.
"Other colleagues including nurses, vet techs and patient care assistants are similarly vulnerable. “We decided to make wearing of hard hats mandatory in order to protect all of our colleagues and minimise the potential risk of head injury, understanding it can never be fully eliminated.
"We recognise that this policy shift represents a degree of change but hope that it serves to further support and progress the equine veterinary industry more widely. “Our policy is evidence-based, utilising three years of rigorous research, and we will continue our efforts in the future to grow our knowledge and understanding of this important area.
"By doing so, we join other industries – such as construction – who have already adopted similar changes to the extent they are now established in their culture.”
https://www.sciencedirect.com/science/article/pii/S0167587725001266
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
ESCCAP says that the risk of novel parasites and zoonoses spreading to new regions has risen alongside an increase in pet travel and changing climate conditions.
ESCCAP’s Guideline 09 offers detailed advice on how to protect dogs and cats that travel or are imported across European borders, minimise the risk of zoonotic transmission and prevent the establishment of new parasites in previously unaffected areas.
Topics covered in the guideline include:
The guideline emphasises the importance of early detection of parasitic infections by thorough clinical examinations, comprehensive travel history assessments and targeted diagnostic testing.
It also provides guidance on educating pet owners about zoonotic risks and implementing appropriate treatments and follow-up screenings.
www.esccap.org/guidelines/gl9/
Vet-AI's automated triage app offers instant advice to pet owners 24/7, early detection of health issues and advice as to whether they need to speak to a vet.
For the blinded test, which was conducted in April 2025, three UK veterinary surgeons reviewed the responses from Vet-AI, Gemini 2.0 and ChatGPT 4.0 to 48 simulated enquiries from owners.
The vets evaluated each on clinical accuracy, triage effectiveness and the subjective criteria of factuality, integrity, safety, empathy and readability.
Vet-AI’s Large Language Model (LLM) achieved an accuracy score of 81%, surpassing Gemini (69%) and ChatGPT (50%).
Vet-AI’s model also stopped triage at the correct point in 81% of cases according to the vets, compared with Gemini’s 75% and ChatGPT’s 56%.
Vet-AI’s tool also outperformed the leading LLMs on subjective measures, delivering more empathetic, thorough and factual responses to pet owners.
Samantha Webster, Chief Veterinary Officer at Vet-AI said: “These latest results are a significant milestone in the development of automated triage.
"We’re proving we can provide trustworthy online pet care by combining clinical and technical expertise.
"This tool can support the wider industry too, engaging more pet owners in the first step of vet care, ensuring their pets get the care they need - whether in practice or remotely.
"We know that an increasing percentage of the UK pet population is struggling to access veterinary care.
"Whilst AI will never replace a vet, the use of innovative technology can break down the barrier to access, leading to more pets getting the care they need, when they need it."
“With this level of clinical accuracy and technical innovation, we're helping to bring great pet care to more people. As well as helping to create more demand for vet services by making the triage of pets as accurate as possible,” said Paul Hallett, Vet-AI founder and exec chair.
https://www.vet-ai.com/automated-triage
Presented by The Webinar Vet and Vet Dynamics, the Vet Trust Awards celebrate notable contributions to veterinary advancement.
Claire Towers, General Manager of Hill’s Pet Nutrition UK and Ireland said: “Our recognition as the most trusted pet food brand is a testament to the unwavering dedication of the Hill’s team, ensuring vets remain integral to our mission.”
The March 2025 Cattle Highlights Report from the Royal GD in the Netherlands has revealed that the proportion of paromomycin-resistant isolates has jumped from 48% in 2021 to 72% in 2024.
The report also highlights an increase in the detection of cryptosporidiosis in calves up to 14 days of age.
MSD says that while it is unclear whether paromomycin is being used to treat E.coli or cryptosporidiosis, the rising use of the antibiotic could be contributing to greater exposure and increased resistance in E.coli K99.
Kat Baxter-Smith MRCVS (pictured), a vet advisor at MSD Animal Health, said: “What we need now is a mindset shift—moving away from routine antibiotic use and towards a more robust, preventative management strategy.
“It’s not about eliminating treatment altogether but using it only when it is really needed.”
“Vaccination, clean pens, and ensuring that every calf receives the right volume and quality of colostrum are the real cornerstones of effective scour control.
“Using vaccines such as Bovilis Rotavec Corona for rotavirus, coronavirus, and E.coli and Bovilis Cryptium for Cryptosporidium parvum is one of the most effective ways to reduce the incidence of neonatal diarrhoea.
"By vaccinating the dam, we ensure the calf has the best possible immunity at birth by ingesting the fortified colostrum and transition milk in the first days of life, which significantly reduces reliance on antibiotics and minimises disease risks.”
The report emphasises best-practice principles such as effective colostrum management, good hygiene and housing, balanced dry cow transition and strategic vaccination of the dam.
The report also recommends halofuginone (Halocur) as the first-line treatment for cryptosporidiosis, due to its targeted action and significantly lower risk of contributing to AMR.
Kat added: "By embracing these proactive strategies, vets and farmers can take a crucial step towards safeguarding calf health, reducing reliance on antibiotics, and combating the growing threat of antimicrobial resistance.”
https://issuu.com/gezondheidsdienstvoordieren/docs/highlights_report_cattle-march_2025
The factsheets, which cover canine chronic bronchitis, feline asthma and equine asthma, are designed to help explain complex conditions more effectively, encourage earlier diagnosis, and improve treatment compliance.
The downloadable factsheets can be printed, emailed to clients, or displayed in waiting areas and on waiting room screens.
Jon Slattery MRCVS, Director of BreathEazy, said: “We often see a seasonal spike in respiratory cases at this time of year, particularly in animals with underlying conditions.
"Having owners on board and confident in managing their pet’s condition is a key part of treatment success.
"These factsheets offer a time-saving way for vets and nurses to educate clients, reinforce advice given in consults, and help owners understand how to support their pets at home.”
https://mailchi.mp/breatheazy/resourcedownload
www.breatheazy.co.uk
The guide is aimed at established practices, new start-ups and those who may be thinking about setting up a practice.
It includes practical information, videos and first hand advice from independent practice leaders who are members of Vetsure and who've successfully navigated the challenges of practice ownership and management.
In the book, Diane Storer of Cockburn Vets offers tips for recruiting and building a collaborative team, whilst Julie Hutton of Hilltop Vets shares her thoughts on leadership and addressing practice challenges.
Other contributors to the guide include Vicki Farbon of Scott Veterinary Clinic, Kate Hornby of Wild Side Vets, Emily Nightingale of Nightingale Vets and Simon Hayes of Creature Comforts, who draw from their diverse experiences of founding and operating independent practices.
Ashley Gray, Managing Director of Vetsure said: “The insights from successful independent practice owners and Vetsure network members included in the guide offer lessons from real experiences beyond generic business courses."
He added: “The Vetsure network aims to support and champion independent veterinary practices by sharing knowledge and expertise, facilitating learning from fresh perspectives and ideas, and fostering genuine collaboration,”
https://www.vetsurevet.com/guide-to-success
To mark the end of his presidential year at BSAVA, Julian will be strapped to the top of a vintage biplane while dressed in a full feline (Cheshire Cat) costume, to support the research that BSAVA PetSavers funds to improve the health and wellbeing of pets across the UK.
BSAVA PetSavers is one of the UK’s few funding bodies focused solely on clinical research into diseases affecting companion animals.
To date, it has invested more than £2.7 million in vital studies addressing conditions such as cancer, heart disease, neurological and joint disorders, gastrointestinal issues.
Julian said: "Every day, vets face the heart-wrenching task of managing the distress and pain our pets suffer due to disease or poor health.
"With your support, we can ensure that they have access to the latest knowledge and resources needed to provide the best care possible.
“The need for advanced research is more pressing than ever and our pets deserve every chance at a healthy life.
"If dressing up as a cat and flying on the wing of a plane makes people take notice of the vital need for pet health research, then it will be worth it.”
Alison Selby, Fundraising Manager for BSAVA PetSavers said: “No one has ever been quite so daring in their fundraising efforts for us, so we are thrilled that Julian has decided to take this on to raise awareness and funds for BSAVA PetSavers.
“For every grant application that we fund, at least two or more are declined due to lack of funds. Fundraising events like this helps to land more funding in the hands of researchers who make a real difference in the veterinary community and directly impact the lives of countless pets and their families.”
Julian’s wing walk is on the 29th May and his target is to fundraise £1,000.
https://www.justgiving.com/page/julian-hoad-2
The company says the webinar, presented by Dechra veterinary technical advisor, Emily Casey BVM&S MRCVS (pictured), will save vets' time and enhance their canine patients’ quality of life.
Emily said: “Canine Cushing’s syndrome can seem over-complicated, and we receive about 200 calls a month on the disease, so we’ve seen it all.
"Our new webinar will provide vets with a straightforward, no-nonsense approach to Cushing’s that will transform how they manage their next canine Cushing’s case.”
Delegates who join the webinar live will be entered into a prize draw to win a Littman Classic III Stethoscope.
https://go.dechra.co.uk/3-things-about-cushings
Super early bird tickets are available till 28th May.
Rose’s programme recommendations are:
BEVA Congress programme will be embracing the overarching theme of “use it wisely or lose it forever”, chosen by BEVA President Bruce Bladon.
Bruce said: “Antibiotics is an issue which goes so far beyond equine practice and is one of the genuine threats to humanity.
"We must use these precious and finite resource wisely, or, quite reasonably, regulators will prevent us having access to them.
“But this theme resonates further, to the “social licence” which threatens the future of equine sport.
"Rather than platitudes about horse welfare, we now need to show the positive steps we can take to minimise equine injury.
"We need to be developing screening programmes and to be instrumental in safety programmes.
"Otherwise, we may lose equestrian sport forever.”
Individual super early bird BEVA members prices for a three-day pass are £539 for vets for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Super early bird ends on 28 May 2025.
http://www.bevacongress.org
The map gives an overview of the regulation applying to virtual care in different countries and it shows how virtual veterinary care is regulated predominantly in Western European countries only.
For the countries where veterinary virtual care is subject to regulation, the new map shows which countries:
https://vvca.org/resources/europe
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
Reference
The award, which is sponsored by Zoetis, celebrates vets in the first eight years of their career who have shown outstanding care, dedication or success.
Nominees may have delivered exceptional care to a patient, made a positive contribution to their community or the wider veterinary profession, or shown their dedication to a cause.
Early career vets who are keen to demonstrate their ambition and dedication to the profession can also self-nominate for the award.
British Veterinary Association President Elizabeth Mullineaux said: “We know how hard all vets work to care for the UK’s animals and to protect both human and animal health and welfare.
"Our young and early career vets deserve to have their incredible work recognised and this award is an opportunity to highlight their compassion, skills and positive contribution to the profession.”
The winner will be announced on Thursday 16th October 2025 at the BVA Awards in London, where they will be awarded a prize package which includes £1,000, a year of free BVA membership and mentoring/engagement opportunity with Zoetis.
The deadline for entries is 9am on Monday 4th August 2025.
www.bva.co.uk/YVOTY
Photo: Last year's winner, David Charles.
The study is being conducted with pet owners and veterinary professionals to develop a greater understanding about how flea and tick treatments are used on cats and dogs.
It will involve two depth surveys to explore the type and format of treatments used, the frequency of application, where treatments are bought, what influences the choice of product, whether there is an awareness of ectoparasiticides’ environmental effect and what preventative steps the public and clinicians would take when using the treatments on animals in the future.
At a later stage, the research project will also include lab assessments of ectoparasiticide residues collected from companion animals to provide more information on their potential environmental impact.
It is hoped the research findings will help the veterinary profession develop the most appropriate approaches to ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’.
Project leader Professor Richard Wall from the University of Bristol, said: “This is an issue of considerable concern.
"Citizen science and laboratory research evidence is urgently needed so that risk-based assessments of the impact of and requirements for ectoparasite treatment can be made.
"Whilst we can make some assumptions around the impact of routine ectoparasite treatments, these findings are essential for us to truly understand them - and to be able to balance the needs of veterinary patients with their wider environmental impacts.”
https://forms.office.com/e/mbztbYf4Ru.
The Health Products Regulatory Authority (HPRA) has also granted a marketing authorisation in exceptional circumstances (Article 25, 26 EU Reg 2019/6) for Bultavo 3 in Ireland.
The company says that so far, more than 40 million doses of Bultavo 3 have been distributed in Europe to help limit the spread of BTV-3.
Boehringer points to a recent field study published by the German reference laboratory Friedrich-Loeffler-Institut (FLI), which showed that vaccination of sheep and cattle with Bultavo 3 induces immunity against the virus1.
According to the study, animals vaccinated with Bultavo 3 consistently showed evidence of a protective antibody response to BTV-3, although animals vaccinated with other BTV-3 vaccines did not1.
Boehringer says it is now compiling the data needed to obtain a full marketing authorisation in accordance with Article 8 of EU Regulation 2019/6.
Bravecto Triuno is approved for the treatment of tick and flea infestations in dogs (Ctenocephalides felis, C. canis, Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus, and Rhipicephalus sanguineus).
It is also approved for the treatment of infections with roundworms (adult stages of Toxocara canis and Toxascaris leonina) and hookworms (L4, immature adult (L5), and adult stages of Ancylostoma caninum and Uncinaria stenocephala), for the prevention of heartworm disease (caused by Dirofilaria immitis), and for the prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).
Victoria Miles, UK Companion Animal Director, MSD Animal Health, said: “With this latest formulation of Bravecto, MSD Animal Health is giving veterinarians and dog owners a greater range of convenient options for protecting their dog year-round from parasites, and all from the same trusted Bravecto portfolio.”
She added: “We see Bravecto Triuno as a great option for puppies that require a monthly wormer on top of protection against fleas and ticks.
"This also gives flexibility later on for the dog to remain with the Bravecto brand but be swapped onto a longer-duration flea and tick product with a wormer administered according to a veterinarian’s risk-based assessment.”
Bravecto Triuno is available as a flavoured chewable tablet indicated for dogs and puppies from 8 weeks of age and at least 1.27 Kg body weight and can be administered monthly to dogs at risk of infestation by multiple types of internal and external parasites.
It contains three anti-parasitic ingredients including fluralaner, which provides activity against ticks and fleas, moxidectin, which provides systemic activity against non-intestinal worms, and pyrantel, which provides activity against intestinal worms.
https://www.noahcompendium.co.uk/?id=-488423
Mr Georgescu faced three sets of charges:
The first was that in April 2024 at Newcastle Magistrates’ Court, he pleaded guilty to driving a car when the proportion of the controlled substance Benzoylecgonine (the main metabolite of cocaine) exceeded the specified limit contrary to the Road Traffic Act 1988 and the Road Traffic Offenders Act.
He was disqualified from driving for 20 months, fined £634, ordered to pay £254 victim surcharge and £150 costs.
The second and third charges were that he was misleading and/or dishonest with the RCVS when he was asked to provide information about the circumstances leading to his conviction.
In correspondence with the College, he claimed that the incident happened on his day off, when he was in fact due to work that day.
He also submitted – or allowed to be submitted – a false staff rota for the day of his arrest.
The Disciplinary Committee found the charges against Mr Georgescu proven on the basis of the certificate of conviction and his admission, prior to the hearing, that he had given false information.
The Committee then considered whether the three charges amounted to serious professional misconduct.
The Committee considered the fact that Mr Georgescu was driving, and intending to work, while he was seven times over the prescribed proportion of Benzoylecgonine allowed to be in in his bloodstream.
Paul Morris, chairing the Committee and speaking on its behalf, said: “With regard to the impact this conduct would have on right thinking members of the public, Dr Georgescu himself said, when cross examined, that were he standing in the shoes of an owner of an animal he was going to treat that day with the knowledge that he had in his blood more than 7 times the prescribed limit of a prohibited drug he “would not be comfortable for sure” and would cause such persons to “lose trust”.
“Having regard to the above facts and matters the Committee has no hesitation in concluding that the facts relevant to his commission of the offence in Charge 1 were so serious and presented such prospective risks to other road users that it renders the respondent unfit to practise as a veterinary surgeon.”
Charges 2 and 3 were considered together, with the Committee again finding serious professional misconduct on the basis that Mr Georgescu had set out to lie to the RCVS and had continued and repeated the lie for a period of six months.
The Committee identified a number of aggravating features in his conduct including the fact it was premeditated, entailed sustained and repeated dishonesty, involved wilful disregard for the role of the RCVS as the veterinary regulator and that admissions were only made when he realised he couldn’t sustain his falsehoods any longer.
Finally, having found that all charges were proven and amounted to serious professional misconduct, the Committee decided that suspending Mr Georgescu from the Register of Veterinary Surgeons would be adequate to protect the welfare of animals, maintain public confidence in the profession, and declare and uphold proper standards of conduct.
Paul Morris added: “The misconduct of the respondent is serious but his misconduct falls short of being fundamentally incompatible with remaining on the Register.
"He does have insight into the seriousness of his misconduct and there is, in the judgement of the Committee, no significant risk of repeat misleading behaviour.
"The Committee also considers that the respondent will be fit to return to practice after the period of suspension in question.
“The Committee did consider striking the respondent from the Register but determined that this sanction would be unduly punitive and deprive the public and the profession of an otherwise competent veterinary surgeon.
“The Committee has reflected carefully on the question of how long the period of suspension should be and has determined that it should be a period which is not so long that it will result in the loss of the respondent to the profession which he professes to love and in which his referees assert he is a capable and caring veterinary surgeon.”
www.rcvs.org.uk/disciplinary
The VetCompass database now holds millions of anonymised veterinary clinical records collected from primary practices and referral centres across the UK.
The records allow researchers to investigate a range and frequency of companion animal health problems and identify important risk factors for the most common disorders.
This research can then be used by veterinary professionals in clinical practice to help improve education and outcomes related to animal welfare.
Dan’s nomination included recognition for VetCompass operating under non-profit and open-access principles and embedding mandatory welfare pathways into all studies.
VetCompass was also recognised for having supported more than 140 research papers supporting broad welfare initiatives spanning breed-related health, extreme conformations, welfare scoring, specific disorders, oncology, disease surveillance, prescribing practices, and more.
Dan said: “I am truly humbled to receive this recognition from the RCVS.
"When I moved from clinical practice to the RVC 15 years ago to develop VetCompass as my PhD project, I could only dream of the untapped potential for practising veterinary surgeons and veterinary nurses to contribute to cutting edge science and welfare.
"And now the amazing VetCompass team at the RVC have made that aspiration to redefine the clinical evidence base on companion animal welfare a reality.
"I now need to reset even higher animal welfare dreams for the next 15 years.”
https://www.rvc.ac.uk/vetcompass/about/overview
The extension, which does not collect any data, interrupts searches related to a broad range of mental health and life challenges, including substance misuse, financial struggles, eating disorders, domestic abuse and more, with a positive message of hope and signposts to a variety of different mental health services.
According to R;ipple, its extension has now interrupted over 100,000 harmful online searches and 32 people so far say they are still alive today because the software intervened at a moment of crisis.
Nick Berryman from Agilio said: “Our commitment aligns with R;pple's mission to combat the stigma surrounding mental health and provide essential resources for those at risk.
"As part of this, we have implemented the tool across our own organisation to safeguard the wellbeing of our staff.
"In parallel, by supporting R;pple’s wider initiatives, we are helping to raise awareness and empower healthcare communities to take proactive steps in supporting those in need.”
R;ipple will be holding a live webinar on Tuesday 7th May at 1pm: Supporting workplace mental health and suicide prevention: my brother’s legacy.
In the webinar, R;ipple founder Alice Hendy MBE will draw on her experience of having lost her brother, Josh, to suicide in 2020 at the age of 21, and explain how healthcare organisations can create safer, more supportive environments through practical steps and awareness.
To register to attend, visit https://tinyurl.com/my-brother-s-legacy.
https://www.ripplesuicideprevention.com
https://agiliosoftware.com/
606 veterinary professionals took part in the research, mostly Practice Managers (34%), Head Nurses (23%) Head Vets (22%) and Administrators (9%)
Of all the respondents, which included those newly-promoted, early career, middle management, senior management and principal leaders, 33% of respondents described their competence as ‘intermediate’, 47% as intermediate, 18% as 'advanced' and only 2% as ‘expert’.
The VMG says its report raises fresh concerns about the preparedness of those tasked with steering veterinary teams through an increasingly complex and demanding landscape.
Rebecca Robinson MRCVS (pictured), incoming VMG President, said: “This year’s report again highlights the urgent need to equip both current and future leaders with the skills and support they need to thrive.
"While there are encouraging signs of progress, we must act with greater urgency as a profession to embed leadership development at every level - especially for those stepping into leadership roles for the first time."
“We encourage all members of the veterinary team to invest in developing their communication and influencing skills well before they take on leadership roles.
"Gaining experience in these areas early on will better prepare them for the demands of leadership and empower them to take charge of their career journeys.
“We also call on employers to make leadership development a priority."
The VMG offers a range of Institute of Leadership and Management-accredited qualifications – the Award, Certificate and Diploma in Veterinary Leadership and Management.
https://vetmg.com/qualifications/cvlm/
The survey, which takes about three minutes, will assess horse owners’ experiences of strangles and includes questions on the disease including preventative measures and vaccination.
There will be a prize draw from completed entries and the winner will get two VIP tickets to Your Horse Live 2025.
Rachel Harrison-Osborne MRCVS, equine field manager at Dechra said: “The strangles survey will provide us with a valuable insight into horse owners’ experiences of the disease and will enable us to identify any trends that may exist to help us support owners who wish to put in place preventative measures to help prevent strangles.”
https://forms.office.com/e/85gzEd7J7A
Photo: Redwings Horse Sanctuary
The researchers’ objective was to determine whether dogs with intracranial space occupying lesions (iSOLs) on MRI, or MRI-determined indicators of intracranial hypertension (ICH) had higher sedation scores with a more rapid onset of recumbency after the administration of IV butorphanol than dogs without intracranial disease.
They hypothesised that 0.2 mg kg-1 of butorphanol administered intravenously would result in statistically significantly higher sedation scores and quicker onset of recumbency in dogs with MRI-iSOL and MRI-ICH.
For the observational study: 'The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension', 53 dogs presented for a brain MRI.
Each dog was sedated with 0.2 mg kg-1butorphanol IV, and the quality of sedation and the onset of recumbency were scored before drug administration and every 5 minutes after administration for 15 minutes using a modified sedation scale.
The maximum sedation score was 18, and onset of recumbency was recorded when a dog lay down without the ability to stand.
Dogs with MRI-iSOL had significantly higher median sedation scores than dogs without MRI-iSOL (12 versus 5 respectively) 15 minutes after butorphanol administration (T15, p < 0.01).
A greater number of dogs with MRI-ICH achieved recumbency (n = 9/10; 90%) than those without MRI-ICH (n = 20/43; 46.5%; p = 0.01).
Emma Sansby, Resident in Anaesthesia and Analgesia at Lumbry Park Veterinary Specialists, who led the research, said: “When intracranial disease is suspected, the administration of butorphanol as a premedicant for anaesthesia could be used to predict the presence of MRI-iSOL and MRI-ICH.
"If a dog becomes recumbent or has a sedation score of more than 10 within 15 minutes of butorphanol administration, the animal should be treated with an anaesthesia protocol adapted to the presence of ICH – so as not to increase intracranial pressure.
“These adaptations include but are not limited to; adequate preoxygenation - to prevent hypoxaemia and elevation of the head to no more than 30 degrees; preventing increases in central venous pressure - by avoiding jugular compression and avoiding excessive intraabdominal and intrathoracic pressure; and a smooth anaesthetic induction - ensuring an adequate depth of anaesthesia prior to tracheal intubation to prevent the cough reflex and judicious mechanical ventilation to enable a low-normal end-tidal carbon dioxide.”
Photo: www.depositphotos.com